Chris Whitman is Vice President of the US Flu Franchise for Sanofi Pasteur, where he has spent his entire career. In 2009, Chris led the launch of Fluzone® High-Dose and has dedicated the last 11 years to building strategies that expand the use of influenza vaccines.